Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality. At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. The Cellular Therapy Lab (CTL) at Fred Hutch Cancer Center is on the cutting edge of new technologies for cancer therapy, including cell-based immunotherapy. We are committed to advancing treatment options for our patients through the translation of innovative research into clinical practice. We collaborate with our consortium partners (University of Washington and Seattle Children's Hospital) as well as industry (biotechnology) and non-industry external entities. CTL is responsible for all minimally manipulated therapeutic cell processing occurring at Fred Hutch. Procedures range from cryopreservation to flow cytometric enumeration of cell proportions to more complex procedures such as cell selection, enrichment, and depletion. The laboratory is regulated by the Food and Drug Administration (FDA) cGTP/cGMP standards, maintains College of American Pathologists (CAP) certification, and is accredited by the Joint Commission and the Foundation for the Accreditation of Cellular Therapy (FACT). The Cell Therapy Specialist will report to the Cell Therapy Clinical Trials Operations Manager. The primary focus of this position is towards implementation and lifecycle management of cell and gene therapy clinical trials and FDA approved products. This requires practical expertise in cell-based therapeutics in order to translate product handling in new manuals/manual updates into CTL standard operation procedures (SOPs). Furthermore, this requires close collaboration within Cell Therapeutics (CTP) including Apheresis (APH), Cell Therapy Services (CTS), and Quality Assurance (QA), as well as across departments and organizations within/outside Fred Hutchinson Cancer Center, including Principal Investigators (PI), Clinical Coordinators, corporate sponsors and vendors. This role requires strong communication skills, including facility in teaching and training staff and translating cell therapy practices clearly across functions and organizations. This role requires the ability to work independently, and identify, initiate, and execute continual process improvement initiatives for waste reduction and efficiency. 1.0 FTE Monday through Friday - 8a-5p - Onsite
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Number of Employees
501-1,000 employees